MARKET

ORGS

ORGS

Orgenesis Inc
OTCQX
1.890
NaN%
Closed 12:58 05/14 EDT
OPEN
--
PREV CLOSE
1.890
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
10.80
52 WEEK LOW
0.900
MARKET CAP
9.02M
P/E (TTM)
-0.2016
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ORGS last week (0505-0509)?
Weekly Report · 3d ago
Weekly Report: what happened at ORGS last week (0428-0502)?
Weekly Report · 05/05 10:31
Weekly Report: what happened at ORGS last week (0421-0425)?
Weekly Report · 04/28 10:37
Weekly Report: what happened at ORGS last week (0414-0418)?
Weekly Report · 04/21 10:37
Weekly Report: what happened at ORGS last week (0407-0411)?
Weekly Report · 04/14 10:30
Weekly Report: what happened at ORGS last week (0331-0404)?
Weekly Report · 04/07 10:29
Orgenesis Delays 10-K Filing Amid Financial Challenges
TipRanks · 04/01 22:25
Weekly Report: what happened at ORGS last week (0324-0328)?
Weekly Report · 03/31 10:37
More
About ORGS
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.

Webull offers Orgenesis Inc stock information, including OTCQX: ORGS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORGS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORGS stock methods without spending real money on the virtual paper trading platform.